Abstract
The human immunodeficiency virus (HIV), a retrovirus, is known to cause the acquired immunodeficiency syndrome (AIDS) as the HIV infection develops. Efforts on searching new anti-HIV agents to provide effective treatment of HIV infection / AIDS have never been slowed down since the discovery of HIV. Nowadays a promising area of research has focused on preventing HIV entry into host cells, called entry inhibitors, which work differently from the approved anti-HIV drugs. With the discovery of the x-ray crystal structure of the gp120 / CD4 / antibody complex, we have a better understanding of how HIV enters the host cell at the molecular level. These findings undoubtedly provide insights into the development of new drugs or vaccines that might prohibit host cell entry of HIV. Despite their novel mechanism of action, the potential benefits of entry inhibitors are also their potential action against drug-resistant HIV strains, minimal side effects and simplified dosing. The aim of the present article is to make a review to discuss the important compounds HIV-1 entry inhibitors in clinical development, as well as potential compounds under biological evaluation.
Keywords: aids, virus hiv, cd4, anti-hiv drugs, drug-resistant, entry inhibitors
Letters in Drug Design & Discovery
Title: Entry Inhibitors - A New Class of Aids Drugs
Volume: 1 Issue: 3
Author(s): Marcus Vinicius Nora De Souza
Affiliation:
Keywords: aids, virus hiv, cd4, anti-hiv drugs, drug-resistant, entry inhibitors
Abstract: The human immunodeficiency virus (HIV), a retrovirus, is known to cause the acquired immunodeficiency syndrome (AIDS) as the HIV infection develops. Efforts on searching new anti-HIV agents to provide effective treatment of HIV infection / AIDS have never been slowed down since the discovery of HIV. Nowadays a promising area of research has focused on preventing HIV entry into host cells, called entry inhibitors, which work differently from the approved anti-HIV drugs. With the discovery of the x-ray crystal structure of the gp120 / CD4 / antibody complex, we have a better understanding of how HIV enters the host cell at the molecular level. These findings undoubtedly provide insights into the development of new drugs or vaccines that might prohibit host cell entry of HIV. Despite their novel mechanism of action, the potential benefits of entry inhibitors are also their potential action against drug-resistant HIV strains, minimal side effects and simplified dosing. The aim of the present article is to make a review to discuss the important compounds HIV-1 entry inhibitors in clinical development, as well as potential compounds under biological evaluation.
Export Options
About this article
Cite this article as:
De Souza Vinicius Nora Marcus, Entry Inhibitors - A New Class of Aids Drugs, Letters in Drug Design & Discovery 2004; 1 (3) . https://dx.doi.org/10.2174/1570180043398786
DOI https://dx.doi.org/10.2174/1570180043398786 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cultured Adult Animal Neurons and Schwann Cells Give Us New Insights into Diabetic Neuropathy
Current Diabetes Reviews Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Current Pharmaceutical Design The Role of AGEs and AGE Inhibitors in Diabetic Cardiovascular Disease
Current Drug Targets Medical Management of the Diabetic Patient with Coronary Artery Disease
Current Pharmaceutical Design Simvastatin Nanoparticles Loaded Polymeric Film as a Potential Strategy for Diabetic Wound Healing: <i>In Vitro</i> and <i>In Vivo</i> Evaluation
Current Drug Delivery Biochemistry and Neurobiology of Prosaposin: A Potential Therapeutic Neuro-Effector
Central Nervous System Agents in Medicinal Chemistry Lipid Disorders in Diabetes Mellitus and Current Management
Current Pharmaceutical Analysis Diabetes Mellitus: Channeling Care through Cellular Discovery
Current Neurovascular Research Deep Venous Thrombosis Associated with Thalidomide use in a Case of Steroid Dependent Erythema Nodosum Leprosum-a Management Conundrum
Current Drug Safety Variability in the Response to Non-pharmacological Treatments in Patients with Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine An Overview of the Actions of Capsaicin and Its Receptor, TRPV1, and Their Relations to Small Primary Sensory Neurons
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Future Directions in the Treatment of Neuropathic Pain: A Review on Various Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Fenofibrate: A New Treatment for Diabetic Retinopathy. Molecular Mechanisms and Future Perspectives
Current Medicinal Chemistry The Impacts of Some Sedative Drugs on α -Glycosidase, Acetylcholinesterase and Butyrylcholinesterase Enzymes-potential Drugs for Some Metabolic Diseases
Letters in Drug Design & Discovery The Neuro-Vascular Consequence of Diabetes: Foot Amputation and Evaluation of its Risk Factors and Health-Related Economic Impact
Current Vascular Pharmacology Regulation of Vascular Genes by Glucose
Current Pharmaceutical Design Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement
Current Vascular Pharmacology Exploring Old Drugs for the Treatment of Hematological Malignancies
Current Medicinal Chemistry Advances in Drug Discovery and Development for Pediatric Tuberculosis
Mini-Reviews in Medicinal Chemistry Beneficial Effects of Azuki Bean (Vigna angularis) Extract: Anti-Oxidant, Anti-Hypertension, and Treatment for Renal Damage
Current Nutrition & Food Science